The Broad Institute, established in 2004, is a leading biomedical and genomic research center affiliated with MIT, Harvard University, and several prominent hospitals in Boston. Its core mission is to improve human health through innovative research in genomics, bioinformatics, and biomedicine. The institute offers contract research services in areas such as cell circuits, chemical biology, cancer, psychiatric diseases, and population genetics. By focusing on both basic and translational research, the Broad Institute aims to accelerate scientific discovery and its application to medicine.
Notable figures associated with the Broad Institute include its director, Todd Golub. The institute has achieved significant milestones, including advancements in CRISPR technology and prime editing systems. It has made substantial contributions to understanding the genetic basis of diseases and developing new therapeutic approaches. The Broad Institute's collaborative efforts with top-tier academic and medical institutions have positioned it as a pivotal player in the global biomedical research community, driving impactful scientific breakthroughs.

HudsonAlpha Institute for Biotechnology
hudsonalpha.org

New York Genome Center
nygenome.org

Innovative Genomics Institute

MIT Koch Institute for Integrative Cancer Research
ki.mit.edu

Wyss Institute
wyss.harvard.edu

Allen Institute for Brain Science
alleninstitute.org

Genome British Columbia
genomebc.ca

Feinstein Institute for Medical Research

Mass General Brigham
Organizations similar to Broad Institute include HudsonAlpha Institute for Biotechnology, New York Genome Center, Innovative Genomics Institute and MIT Koch Institute for Integrative Cancer Research.
Broad Institute was founded in 2003.
Broad Institute's headquarters is located in Cambridge, MA, US.
As of Aug 11, 2020, Broad Institute has raised a total of $183.3M (USD).
Broad Institute has 750 employees as of Feb 5, 2024.